8D4X
Structure of the human UBR5 HECT-type E3 ubiquitin ligase in a dimeric form
Summary for 8D4X
Entry DOI | 10.2210/pdb8d4x/pdb |
EMDB information | 27201 |
Descriptor | E3 ubiquitin-protein ligase UBR5, ZINC ION (2 entities in total) |
Functional Keywords | hect, e3 ligase, dimer, ligase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 621601.70 |
Authors | |
Primary citation | Wang, F.,He, Q.,Zhan, W.,Yu, Z.,Finkin-Groner, E.,Ma, X.,Lin, G.,Li, H. Structure of the human UBR5 E3 ubiquitin ligase. Structure, 31:541-552.e4, 2023 Cited by PubMed Abstract: The human UBR5 is a single polypeptide chain homology to E6AP C terminus (HECT)-type E3 ubiquitin ligase essential for embryonic development in mammals. Dysregulated UBR5 functions like an oncoprotein to promote cancer growth and metastasis. Here, we report that UBR5 assembles into a dimer and a tetramer. Our cryoelectron microscopy (cryo-EM) structures reveal that two crescent-shaped UBR5 monomers assemble head to tail to form the dimer, and two dimers bind face to face to form the cage-like tetramer with all four catalytic HECT domains facing the central cavity. Importantly, the N-terminal region of one subunit and the HECT of the other form an "intermolecular jaw" in the dimer. We show the jaw-lining residues are important for function, suggesting that the intermolecular jaw functions to recruit ubiquitin-loaded E2 to UBR5. Further work is needed to understand how oligomerization regulates UBR5 ligase activity. This work provides a framework for structure-based anticancer drug development and contributes to a growing appreciation of E3 ligase diversity. PubMed: 37040767DOI: 10.1016/j.str.2023.03.010 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (2.8 Å) |
Structure validation
Download full validation report